Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha--negative ...

Estrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At Baylor College of Medicine, Louisiana State University ...

First, 500 postmenopausal women living in a rural area of the Hai Duong province were screened from two communes by questionnaire. Women who had one or more of the following factors were excluded from ...

CHAMPAIGN, Ill. — Less than 20% of diagnosed breast cancers are designated “triple-negative,” lacking three types of receptors often found in other breast cancer types. But TNBCs have a higher risk of ...

BETHESDA, Md. -- October 18, 2001 -- The American Physiological Society (APS) kicks off a special series entitled, “Highlighted Topics on Gender Differences in Physiology,” beginning with the October ...

Retrospective analysis of clinico-pathological features and outcomes of 2,686 hormone receptors-positive breast cancer (HR+) patients in a consecutive mono-institutional series No significant ...

GTx Announces That GTx-758, a Novel Oral Selective Estrogen Receptor Alpha Agonist Being Developed to Treat Advanced Prostate Cancer, Induced Medical Castration in a Phase II PK/PD Clinical Trial In ...